ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

Author： L’’Huillier Arnaud G   Ing Lorenzini Kuntheavy   Crisinel Pierre-Alex   Rebsamen Michela C   Fluss Joel   Korff Christian M   Barbe Remy P   Siegrist Claire-Anne   Dayer Pierre   Posfay-Barbe Klara M   Desmeules Jules A  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.10, 2011-10, pp. : 1493-1501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: A Comprehensive Review

By Toovey Stephen  

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1097-1114

Adis International

Access to resources Recommend Favorite

Oseltamivir: Development of resistance during treatment of influenza A virus H1N1 subtype in children: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1364, 2011-01 ,pp. : 35-35

Adis International

Access to resources Recommend Favorite

Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis

By Jones Mark  

Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. : 1187-1188

Adis International

Access to resources Recommend Favorite

Oseltamivir, zanamivir leading the charge against influenza H5N1

By  

Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Sensitivity of H5N1 influenza viruses to oseltamivir: an update

By Rameix-Welti Marie-Anne   van der Werf Sylvie   Naffakh Nadia  

Future Virology, Vol. 3, Iss. 2, 2008-03 ,pp. : 157-165

Future Medicine

Access to resources Recommend Favorite